HOWARD CONSULTING GROUP, INC. for PHRMA ON BEHALF OF WE WORK FOR HEALTH
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
-The impact of medical innovation on the local economy -The impact of Biosimilars legislation on the pharmaceutical industry -Prevention and wellness education programs focused on chronic disease -House Tri-Committee Health Reform Discussion draft -Senate Finance Committee options papers -H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval for follow-on biologics, including provisions on data exclusivity and patient procedures for biologics -H.R. 1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics -S. 726, Promoting Innovation and Access to Life-Saving Medicines Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics -The "America's Healthy Futures Act of 2009"
| Lobbyist | Covered position, as disclosed |
|---|---|
| FRANK HOWARD | — |
| JOHN MARCHANT | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.